149 related articles for article (PubMed ID: 11353643)
1. In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B.
Moore CB; Walls CM; Denning DW
Antimicrob Agents Chemother; 2001 Jun; 45(6):1882-5. PubMed ID: 11353643
[TBL] [Abstract][Full Text] [Related]
2. In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp.
Mosquera J; Sharp A; Moore CB; Warn PA; Denning DW
J Antimicrob Chemother; 2002 Aug; 50(2):189-94. PubMed ID: 12161398
[TBL] [Abstract][Full Text] [Related]
3. Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species.
Ryder NS; Leitner I
Med Mycol; 2001 Feb; 39(1):91-5. PubMed ID: 11270414
[TBL] [Abstract][Full Text] [Related]
4. In-vitro activities of terbinafine, itraconazole and amphotericin B against Aspergillus and Cladosporium species.
Kantarcioğlu AS; Yucel A
J Chemother; 2002 Dec; 14(6):562-7. PubMed ID: 12583546
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of the new triazole BMS-207147 against Aspergillus species in comparison with itraconazole and amphotericin B.
Moore CB; Walls CM; Denning DW
Antimicrob Agents Chemother; 2000 Feb; 44(2):441-3. PubMed ID: 10639380
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
Wang HC; Hsieh MI; Choi PC; Wu CJ
J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of terbinafine and itraconazole against Aspergillus species isolated from otomycosis.
Karaarslan A; Arikan S; Ozcan M; Ozcan KM
Mycoses; 2004 Aug; 47(7):284-7. PubMed ID: 15310330
[TBL] [Abstract][Full Text] [Related]
8. In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole.
Dannaoui E; Persat F; Monier MF; Borel E; Piens MA; Picot S
J Antimicrob Chemother; 1999 Oct; 44(4):553-5. PubMed ID: 10588320
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of amphotericin B, terbinafine, and azole drugs against clinical and environmental isolates of Aspergillus terreus sensu stricto.
Fernández MS; Rojas FD; Cattana ME; Sosa Mde L; Iovannitti CA; Lass-Flörl C; Giusiano GE
Antimicrob Agents Chemother; 2015; 59(6):3619-22. PubMed ID: 25824228
[TBL] [Abstract][Full Text] [Related]
10. MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp.
Schmitt HJ; Bernard EM; Andrade J; Edwards F; Schmitt B; Armstrong D
Antimicrob Agents Chemother; 1988 May; 32(5):780-1. PubMed ID: 3134851
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
Shi JY; Xu YC; Shi Y; Lü HX; Liu Y; Zhao WS; Chen DM; Xi LY; Zhou X; Wang H; Guo LN
Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of three licensed antifungal agents against spanish clinical isolates of Aspergillus spp.
Gomez-Lopez A; Garcia-Effron G; Mellado E; Monzon A; Rodriguez-Tudela JL; Cuenca-Estrella M
Antimicrob Agents Chemother; 2003 Oct; 47(10):3085-8. PubMed ID: 14506013
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp.
Oakley KL; Moore CB; Denning DW
Antimicrob Agents Chemother; 1997 May; 41(5):1124-6. PubMed ID: 9145880
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of combination of terbinafine with itraconazole or amphotericin B against Zygomycota.
Gómez-López A; Cuenca-Estrella M; Mellado E; Rodríguez-Tudela JL
Diagn Microbiol Infect Dis; 2003 Mar; 45(3):199-202. PubMed ID: 12663161
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of the type of interaction obtained by the combination of terbinafine and itraconazole, voriconazole, or amphotericin B against dematiaceous molds.
Biancalana FS; Lyra L; Schreiber AZ
Antimicrob Agents Chemother; 2011 Sep; 55(9):4485-7. PubMed ID: 21690288
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp.
Oakley KL; Moore CB; Denning DW
Antimicrob Agents Chemother; 1998 Oct; 42(10):2726-30. PubMed ID: 9756785
[TBL] [Abstract][Full Text] [Related]
17. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.
Pfaller MA; Messer SA; Hollis RJ; Jones RN;
Antimicrob Agents Chemother; 2002 Apr; 46(4):1032-7. PubMed ID: 11897586
[TBL] [Abstract][Full Text] [Related]
18. [In vitro activity of amphotericin B, itraconazole and voriconazole against 20 species of Aspergillus using the Sensititre microdilution method].
García-Martos P; García-Agudo L; Gutiérrez-Calzada J; Ruiz-Aragón J; Saldarreaga A; Marín P
Enferm Infecc Microbiol Clin; 2005 Jan; 23(1):15-8. PubMed ID: 15701327
[TBL] [Abstract][Full Text] [Related]
19. In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin B.
Oakley KL; Moore CB; Denning DW
J Antimicrob Chemother; 1998 Jul; 42(1):91-4. PubMed ID: 9700534
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of amphotericin B, itraconazole, terbinafine and 5-fluocytosine against Exophiala spinifera and evaluation of post-antifungal effects.
Vitale RG; De Hoog GS; Verweij PE
Med Mycol; 2003 Aug; 41(4):301-7. PubMed ID: 12964723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
